CLINICAL_TRIALS
research
· 2024-05-02
Clinical Trial Update: Stemchymal® for Polyglutamine Spinocerebellar Ataxia [Phase 2]
Summary
Clinical trial update for Stemchymal in polyglutamine spinocerebellar ataxia, a Phase 2 study that is NOT_YET_RECRUITING.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Steminent US, Inc. | Conditions: Spinocerebellar Ataxias | Phase 2 | Status: NOT_YET_RECRUITING